【招银国际】Multiple growth drivers and improving margin to continue into 2025; Raise TP to HK$53.48.pdf

Operating efficiency improvement on track

New relocation travel process improves global mobility for pharma company

Valuation to improve on ODM business spin-off

Improving Trust and Security in Open Source Projects

CoR sequentially improved turning to positive 2Q net profit growth; first interim dividend in place

Proving That Manager Actions Improve Engagement

Improved earnings visibility favours re-rating

Earnings outlook to mildly improve

Improving cost efficiency with rapid sales growt

China Economy–Exports improved thanks to base effect and price factor